Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 3 analysts offering 12 month price targets for Nuvectis Pharma Inc have a median target of 21.00, with a high estimate of 25.00 and a low estimate of 20.00. The median estimate represents a 211.11% increase from the last price of 6.75.
High | 270.4% | 25.00 |
Med | 211.1% | 21.00 |
Low | 196.3% | 20.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 08, 2024.
Average growth rate | +6.71% |
Average growth rate | +27.65% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | 0.00% |
More ▼